What Diligent Pharma does

Diligent Pharma is a Philadelphia- and Princeton, NJ-based private software company founded in 2018 that operates a centralized vendor qualification platform for the clinical trial industry. The company's core product, Diligent360, connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring. It is supplemented by VendorBase, a global database of clinical vendors with data on capabilities, experience, qualification, and compliance, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster while demonstrating ICH and regulatory compliance. SME-led risk scoring and a regulation-based RFI and Audit Report Library are positioned as the primary differentiators, with the company claiming reduction of vendor qualification timelines from months to days and significant audit hours saved for clients since 2021.

The business operates as an enterprise SaaS on a subscription/recurring revenue model, selling directly to pharmaceutical sponsors and clinical trial vendors through a 'Book a Demo' sales motion that signals quote-based, large-ACV contracts rather than self-serve SMB volume. Pricing is not publicly disclosed. The customer base is segmented vertically — sponsors seeking to mitigate trial risk and shorten start-up timelines, and vendors seeking faster qualification and broader sponsor exposure — addressing pain points such as lengthy qualification cycles, fragmented vendor oversight, and compliance with ICH and global regulatory standards. The company maintains a content marketing and blog presence for top-of-funnel engagement and funnels prospects into demo-driven bottom-of-funnel conversions.

Diligent Pharma completed an $8.27 million Series A financing round in May 2023 led by FCA Venture Partners, with additional participation from PJC and GenHenn Capital. The funding was directed toward expanding the company's data and content strategy for streamlining vendor qualification in clinical trial execution. The company operates with 11-50 employees, is led by founder Patricia Leuchten and President LeRoy Jones, and is incorporated as Diligent Pharma Inc. in the United States. No revenue, ARR, or named customer logos are publicly disclosed.

Name

Diligent Pharma

Legal name

Diligent Pharma Inc.

Website

https://diligentpharma.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Diligent Pharma operates Diligent360, a centralized SaaS platform that connects pharmaceutical sponsors and clinical trial vendors for risk-based vendor discovery, qualification, and monitoring, supported by VendorBase (a global vendor database) and Diligent Respond (automated RFI questionnaire tool).

Ownership category

akta.pro rank

Product category

Clinical Trial Management Software

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH)

akta.pro secondary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Clinical trial vendor qualification
• Clinical trial management software
• Pharmaceutical vendor management
• Clinical vendor database
• RFI management software

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Platform Subscription: SaaS-based platform access for sponsors and vendors. The company operates as a private vendor qualification organization providing centralized vendor management solutions for clinical trial management.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Diligent Pharma provides a centralized SaaS platform (Diligent360) that connects pharmaceutical sponsors and clinical trial vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials. The offering is complemented by VendorBase, a global database of clinical vendors with capabilities and compliance data, and Diligent Respond, an automated questionnaire tool that helps vendors complete RFI forms faster.

Product overview

Diligent Pharma offers a platform-plus-modules architecture centered on Diligent360 as the core unified platform, supplemented by VendorBase (a global Vendor database) and Diligent Respond (an automated questionnaire tool). The core platform connects Sponsors and Vendors for risk-based Vendor discovery, qualification, and monitoring, while VendorBase provides the underlying data repository and Diligent Respond enables efficient Vendor questionnaire completion.

Differentiator

Problem solved

Functional benefit

Brands

• Diligent360: Centralized platform that connects Sponsor and Vendors, streamlining risk-based Vendor discovery, qualification, and monitoring for clinical trials
• VendorBase
• Diligent Respond

Products and services

• Diligent360 Centralized vendor management platform that connects pharmaceutical Sponsors and clinical trial Vendors, streamlining risk-based vendor discovery, qualification, and monitoring for clinical trials.
• VendorBase Extensive global database of clinical vendors with robust data on capabilities, experience, qualification, and compliance, featuring sponsors actively seeking partnerships.
• Diligent Respond Automated questionnaire tool that streamlines response management, helping clinical trial vendors complete RFI forms faster and with less effort while demonstrating ICH and regulatory compliance.

Quantifiable outcome

• 3-5 months reduction in qualification timelines
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Veeva Systems: Veeva provides a broad suite of cloud software for life sciences, including Veeva Vault for quality, regulatory, and vendor information management. Comparable to Diligent Pharma because it serves the same pharma sponsor base for vendor and qualification content management, but at much greater scale and breadth.
• IQVIA: IQVIA is a global CRO and life sciences technology provider offering clinical operations, data, and vendor management services. It is comparable as an incumbent that sponsors already rely on for clinical trial vendor oversight, posing a bundling threat to Diligent's narrow focus.
• Oracle Health Sciences (Clinical One): Oracle's Clinical One platform unifies clinical trial operations including trial design, EDC, and vendor integrations. It is comparable because it targets the same pharma sponsor buyers and could absorb vendor qualification workflows into a single platform.
• Medidata (Dassault Systèmes): Medidata offers the Rave clinical cloud used by most large pharma sponsors for trial execution. Comparable to Diligent because it sits in the same sponsor clinical-operations stack and could extend into vendor qualification via integrations or product expansion.
• Clario: Clario provides clinical trial endpoint technology and services used by pharma sponsors and CROs. Comparable because it serves the same clinical operations buyers and offers adjacent tools that overlap with sponsor-vendor workflow management.

Direct peers

• Florence Healthcare: Florence Healthcare connects sponsors and clinical trial sites through eISF and eRegulatory workflows. It is a direct peer because it addresses the same sponsor-vendor/site documentation and oversight burden that Diligent targets, though focused on sites rather than vendors.
• RealTime Software Solutions: RealTime offers CTMS, eRegulatory, and vendor/IRB workflow software to research sites and sponsors. Comparable to Diligent because it serves the sponsor-vendor operational layer of clinical trials with a SaaS platform and shared buyer personas.

Emerging players

• Slope (formerly 4G Clinical): Slope provides clinical trial supply and randomization technology to sponsors and vendors. Comparable as a venture-backed clinical-operations workflow vendor selling to the same pharma sponsor base that Diligent targets with its vendor qualification platform.
• Vial: Vial operates a technology-enabled CRO platform that connects sponsors with clinical research vendors. Comparable because it shares the thesis of digitizing sponsor-vendor coordination in clinical trials, though Vial approaches from the CRO-services side.
• Castor: Castor provides an eClinical platform used by sponsors and CROs for trial data capture and operations. Comparable as a venture-scale clinical operations SaaS vendor pursuing similar pharma sponsor customers and adjacent workflow modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diligent Pharma